Akt3 is predominantly activated in a number of cancers such as malignant melanoma and glioma, and plays important roles in the survival of immortalized MEFs (Liu et al., 2006; Mure et al., 2010; Stahl et al., 2004). Here, AKT3 is linked to central nervous system cancer.